N.H. Admin. Code § Occ 305.03

Current through Register No. 49, December 5, 2024
Section Occ 305.03 - Required Professional Education
(a) The required professional education relating to ultrasound modalities, including phonophoresis, shall:
(1) Be at least 6 hours in duration for occupational therapists and occupational therapy assistants; and
(2) Cover the following topics:
a. Proper use of ultrasound equipment, including:
1. The use of treatment controls;
2. Soundhead selection;
3. Frequency;
4. Application method; and
5. Equipment maintenance as it relates to overall client safety;
b. Knowledge of the clinical use, optimal parameters, precautions and contraindications to determine, prior to administration, the appropriateness of ultrasound for a client;
c. Knowledge of the physiological effect of ultrasound, including the therapeutic benefits as well as the tissue response for both thermal and non-thermal delivery;
d. Understanding of the optimal parameters for maximum therapeutic benefit in regards to:
1. Tissue depth;
2. Tissue type;
3. Intensity;
4. Size of the area to be sonated; and
5. The mode of ultrasound delivery, including but not limited to, pulse, continuous and medication;
e. The appropriate selection and storage of topical drugs:
1. Prescribed by a licensed healthcare practitioner authorized to prescribe medicine; and
2. Used in the ultrasound treatment; and
f. The proper positioning of the client for maximum safety and therapeutic effectiveness.
(b) The required professional education relating to electrical stimulation modalities, including, at a minimum, NMES, TENS, iontophoresis and HVGS, shall:
(1) Be at least 15 hours in duration for occupational therapists and occupational therapy assistants; and
(2) Cover, for each of the specific electrical stimulation modalities listed in (b) above, the following topics:
a. Electrotherapeutic terminology and biophysical principles, including current, voltage and amplitude;
b. The normal electrophysiology of nerve and muscle;
c. The types of current, direct, pulsed and alternating, used for electrical stimulation;
d. The duration and type of current appropriate for the client's neurological status;
e. The following common denominators of electrical currents:
1. Normal and abnormal human responses to direct and alternating current;
2. Current flow effect on tissue, including thermal, chemical and kinetic changes;
3. Waveforms, including:
(i) The true direct current of iontophoresis; and
(ii) Pulsed currents, including monophasic, biphasic and polyphasic;
4. The characteristics of phase, including:
(i) Duration;
(ii) Intensity;
(iii) Charge; and
(iv) Frequency or rate;
5. The modulation of the characteristics listed in e.4. above; and
6. The physiological correlates of the phase characteristics listed in e.4. above;
f. The indications, contraindications, warnings and precautions of electrotherapy, including considerations regarding pathology of nerve and muscle tissue;
g. The rationale and clinical indications of electrotherapy necessary for the safe and appropriate integration in the delivery of occupational therapy;
h. The appropriate selection and storage of topical drugs:
1. Prescribed by a licensed healthcare practitioner authorized to prescribe medicine; and
2. Used in electrical stimulation treatments;
i. The proper positioning of, and adequate instructions to, the client during application of the modality;
j. Appropriate education of the client as to the benefits and risks of the electrotherapeutic treatment;
k. Knowledge of the safe and appropriate operation of the electrical stimulation device and the optimal parameters, including:
1. The intensity;
2. The frequency or rate;
3. The type of current; and
4. The duration of treatment; and
l. The optimal electrode placement, including motor points and physiological effects desired.

N.H. Admin. Code § Occ 305.03

#8297, eff 3-1-05; ss by #8895, eff 6-7-07

Amended by Volume XXXV Number 32, Filed August 13, 2015, Proposed by #10901, Effective 7/29/2015, Expires7/29/2025.
Amended by Volume XLII Number 2, Filed January 13, 2022, Proposed by #13257, Effective 12/21/2021, Expires 12/21/2031